Recent Quotes
My Watchlist
Indicators
Silicon Valley 150
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Singular Genomics Systems Inc (NQ: OMIC )

8.260 -0.150 (-1.78%)
Streaming Delayed Price Updated: 11:00 AM EDT, Jul 5, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Singular Genomics Systems Inc

< Previous 1 2 3 4 5 Next >
OMIC Stock Earnings: Singular Genomics Sys Beats EPS, Misses Revenue for Q2 2023
OMIC stock results show that Singular Genomics Sys beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2023. 
Via InvestorPlace
Enerpac Tool Group, Singular Genomics Systems And 3 Stocks To Watch On Monday
Via Benzinga
Singular Genomics Announces 1-for-30 Reverse Stock Split
From Singular Genomics Systems, Inc.
Via GlobeNewswire
Singular Genomics to Present at the Goldman Sachs Global Healthcare Conference
From Singular Genomics Systems, Inc.
Via GlobeNewswire
Singular Genomics Sys: Q4 Earnings Insights
Via Benzinga
Preview: Singular Genomics Sys's Earnings
Via Benzinga
Recap: Singular Genomics Sys Q3 Earnings
Via Benzinga
OMIC Stock Earnings: Singular Genomics Sys Beats EPS, Beats Revenue for Q1 2024
OMIC stock results show that Singular Genomics Sys beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
Singular Genomics Reports Recent Highlights and First Quarter 2024 Financial Results
From Singular Genomics Systems, Inc.
Via GlobeNewswire
Singular Genomics to Report First Quarter 2024 Financial Results on May 14, 2024
From Singular Genomics Systems, Inc.
Via GlobeNewswire
OMIC Stock Earnings: Singular Genomics Sys Beats EPS, Beats Revenue for Q4 2023
OMIC stock results show that Singular Genomics Sys beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023. 
Via InvestorPlace
Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2023 Financial Results
From Singular Genomics Systems, Inc.
Via GlobeNewswire
Earnings Scheduled For March 18, 2024
Companies Reporting Before The Bell • Niu Techs (NASDAQ:NIU) is expected to report earnings for its fourth quarter. 
Via Benzinga
Singular Genomics to Report Fourth Quarter and Full Year 2023 Financial Results on March 18, 2024
From Singular Genomics Systems, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Singular Genomics Showcases New G4X™ Spatial Sequencer at AGBT and Announces Significant Advances in Throughput, Quality, and Usability for G4® Sequencing Platform
From Singular Genomics Systems, Inc.
Via GlobeNewswire
Singular Genomics Unveils G4X™ Spatial Sequencer, Transforming the Landscape of In Situ Multiomic Analysis
From Singular Genomics Systems, Inc.
Via GlobeNewswire
Singular Genomics Reports Instrument Shipments and Preliminary Unaudited Fourth Quarter 2023 Revenue
From Singular Genomics Systems, Inc.
Via GlobeNewswire
Singular Genomics Reports Recent Highlights and Third Quarter 2023 Financial Results
From Singular Genomics Systems, Inc.
Via GlobeNewswire
Why INVO Bioscience Shares Are Trading Higher By Over 31%; Here Are 20 Stocks Moving Premarket
INVO Bioscience, Inc. (NASDAQ: INVO) shares surged in pre-market trading after the company posted a narrower loss for the third quarter. 
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Pre-market stock movers are worth checking out on Monday as we cover all of the biggest gainers and losers this morning! 
Via InvestorPlace
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Singular Genomics to Report Third Quarter 2023 Financial Results on November 14, 2023
From Singular Genomics Systems, Inc.
Via GlobeNewswire
Why Sanmina Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers PaxMedica, Inc. (NASDAQ: PXMD) shares climbed 173.8% to $8.35. PaxMedica announced the publication of its autism spectrum disorder Phase 2 study results in the Annals of General Psychiatry. 
Via Benzinga
Beware! 3 Biotech Stocks Waving Massive Red Flags Right Now
There are always many biotech stocks to avoid and these firms are among the clearest choices currently to steer clear of. 
Via InvestorPlace
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
  During Tuesday's session, 275 companies made new 52-week lows. 
Via Benzinga
Singular Genomics to Present at the Gilmartin Group Emerging Growth Company Showcase
From Singular Genomics Systems, Inc.
Via GlobeNewswire
Stocks That Hit 52-Week Lows On Thursday
  On Thursday, 283 companies set new 52-week lows. 
Via Benzinga
< Previous 1 2 3 4 5 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.